1. International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use. E26(R2) Guideline for Good Clinical Practices. 2016.
https://www.ich.org/fileadmin/Public_Web_Site/ICH_Products/Guidelines/Efficacy/E6/E6_R2__Step_4_2016_1109.pdf
. Accessed 10 Dec 2018.
2. Medicine and Healthcare products Regulatory Agency. GCP inspection metrics report. 2018.
https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/706356/GCP_INSPECTIONS_METRICS_2016-2017__final_11-05-18_.pdf
. Accessed 10 Dec 2018.
3. Food and Drug Administration. 2018 inspection data set.
https://www.fda.gov/downloads/ICECI/Inspections/UCM628362.xlsx
. Accessed 10 Dec 2018.
4. Food and Drug Administration. Guidance for Industry: Investigator Responsibilities — Protecting the Rights, Safety, and Welfare of Study Subjects. 2009.
https://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM187772.pdf
. Accessed 10 Dec 2018.
5. Pitrou I, Boutron I, Ahmad N, Ravaud P. Reporting of safety results in published reports of randomized controlled trials. Arch Intern Med. 2009;169(19):1756–61.